J.B. Chemicals & Pharmaceuticals has announced the appointment of Mr. Aman Mehta as Managing Director, effective January 21, 2026, for a 3-year term. Additionally, Mr. Amal Kelshikar, Mr. Hasmukh Patel, and Mr. Sudhir Menon have been appointed as Non-Executive, Non-Independent Additional Directors. These appointments are subject to shareholder approval and aim to bolster the company’s strategic direction and governance.
Leadership Changes at J.B. Chemicals
J.B. Chemicals & Pharmaceuticals has reshaped its leadership team with key appointments approved at a board meeting held on January 21, 2026.
Key Appointments
Mr. Aman Mehta has been appointed as an Additional Director and Managing Director for a term of 3 years, effective from the conclusion of the meeting on January 21, 2026. His appointment is based on the recommendation of the Nomination and Remuneration Committee and remains subject to shareholder approval.
The company also announced the appointment of the following Non-Executive and Non-Independent Additional Directors, effective January 21, 2026, subject to shareholder approval:
* Mr. Amal Kelshikar
* Mr. Hasmukh Patel
* Mr. Sudhir Menon
Aman Mehta’s Background
*
Managing Director of Torrent Pharmaceuticals Limited.
*
Key contributor to strategic direction.
*
MBA from Columbia University.
Reasoning
The appointments reflect the company’s commitment to strengthening its leadership and governance structure, leveraging the diverse expertise of the new directors to drive future growth and strategic initiatives.
Source: BSE
